Private Capital Management (Florida)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Capital Management (Florida)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,402	Closed	-$2M	–	64
2015 Q4	$2M	Sell	14,402 -275	-2%	-$38.1K	0.25%	57
2015 Q3	$1.97M	Hold	14,677	–	–	0.23%	57
2015 Q2	$2.21M	Sell	14,677 -360	-2%	-$51.5K	0.24%	58
2015 Q1	$2.03M	Sell	15,037 -150	-1%	-$18.6K	0.23%	55
2014 Q4	$1.83M	Hold	15,187	–	–	0.2%	63
2014 Q3	$1.72M	Sell	15,187 -865	-5%	-$102K	0.2%	65
2014 Q2	$1.92M	Sell	16,052 -400	-2%	-$48.8K	0.22%	64
2014 Q1	$2.11M	Hold	16,452	–	–	0.27%	62
2013 Q4	$2.03M	Hold	16,452	–	–	0.25%	62
2013 Q3	$1.93M	Hold	16,452	–	–	0.18%	62
2013 Q2	$1.85M	Buy	+16,452	New	+$1.93M	0.17%	63

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Private Capital Management (Florida)'s BIO Position: Q1 2016 in Review

Private Capital Management (Florida) sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2016, closing a stake of 14,402 shares — an estimated $2M sold.

Private Capital Management (Florida) first reported a position in BIO in Q2 2013 and held it in 11 quarters. The position peaked at $2.21M in Q2 2015. 232 funds tracked by Wall St. Rank hold BIO as of Q1 2016.

Private Capital Management (Florida) reported no remaining Bio-Rad Laboratories Class A position as of Q1 2016 after selling out during the quarter.
Private Capital Management (Florida) sold 14,402 Bio-Rad Laboratories Class A shares in Q1 2016, an estimated $2M.
Private Capital Management (Florida) first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 11 quarters.
Private Capital Management (Florida)'s Bio-Rad Laboratories Class A position peaked at $2.21M in Q2 2015.
232 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2016.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2016, filed 16 May 2016.